1. Labianca R, Beretta GD, Kildani B, et al. Colon cancer. Crit Rev Oncol Hematol 2010; 74: 106-133.
2.
Xi Y and Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol 2021; 14: 101174.
3.
Chen S and Shen X. Long noncoding RNAs: functions and mechanisms in colon cancer. Mol Cancer 2020; 19: 167.
4.
Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002; 31: 925-943.
5.
Xu M, Chang J, Wang W, et al. Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy. Front Immunol 2022; 13: 934083.
6.
Colquhoun PH and Wexner SD. Surgical management of colon cancer. Curr Gastroenterol Rep 2002; 4: 414-419.
7.
Dariya B, Aliya S, Merchant N, et al. Colorectal Cancer Biology, Diagnosis, and Therapeutic Approaches. Crit Rev Oncog 2020; 25: 71-94.
8.
Cheng T, Zhu X, Lu J, et al. MiR-532-3p suppresses cell proliferation, migration and invasion of colon adenocarcinoma via targeting FJX1. Pathol Res Pract 2022; 232: 153835.
9.
Lamouille S, Xu J and Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15: 178-196.
10.
Dongre A and Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 2019; 20: 69-84.
11.
Feng J, Hu S, Liu K, et al. The Role of MicroRNA in the Regulation of Tumor Epithelial-Mesenchymal Transition. Cells 2022; 11.
12.
Setlai BP, Hull R, Reis RM, et al. MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma. Genes (Basel) 2022; 13.
13.
Mohr AM and Mott JL. Overview of microRNA biology. Semin Liver Dis 2015; 35: 3-11.
14.
Bushati N and Cohen SM. microRNA functions. Annu Rev Cell Dev Biol 2007; 23: 175-205.
15.
Ho PTB, Clark IM and Le LTT. MicroRNA-Based Diagnosis and Therapy. Int J Mol Sci 2022; 23.
16.
Lu TX and Rothenberg ME. MicroRNA. J Allergy Clin Immunol 2018; 141: 1202-1207.
17.
Zhang L, Yu L, Liu Y, et al. miR-21-5p promotes cell proliferation by targeting BCL11B in Thp-1 cells. Oncol Lett 2021; 21: 119.
18.
Li N, Wang X, Sun J, et al. miR-21-5p/Tiam1-mediated glycolysis reprogramming drives breast cancer progression via enhancing PFKL stabilization. Carcinogenesis 2022; 43: 705-715.
19.
Jiang R, Chen X, Ge S, et al. MiR-21-5p Induces Pyroptosis in Colorectal Cancer via TGFBI. Front Oncol 2020; 10: 610545.
20.
Tang J, Li X, Cheng T, et al. miR-21-5p/SMAD7 axis promotes the progress of lung cancer. Thorac Cancer 2021; 12: 2307-2313.
21.
Huang H, Li X, Zhang X, et al. DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling. Acta Biochim Biophys Sin (Shanghai) 2022; 54: 1775-1788.
22.
Stylianou P, Clark K, Gooptu B, et al. Tensin1 expression and function in chronic obstructive pulmonary disease. Sci Rep 2019; 9: 18942.
23.
Okayama A, Miyagi Y, Oshita F, et al. Identification of Tyrosine- Phosphorylated Proteins Upregulated during Epithelial- Mesenchymal Transition Induced with TGF-. J Proteome Res 2015; 14: 4127-4136.
24.
Miao Y, Wang J, Ma X, et al. Identification prognosis-associated immune genes in colon adenocarcinoma. Biosci Rep 2020; 40.
25.
Hossain MS, Karuniawati H, Jairoun AA, et al. Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. Cancers (Basel) 2022; 14.
26.
Akrida I, Bravou V and Papadaki H. The deadly cross-talk between Hippo pathway and epithelial-mesenchymal transition (EMT) in cancer. Mol Biol Rep 2022; 49: 10065-10076.
27.
Paolillo M and Schinelli S. Extracellular Matrix Alterations in Metastatic Processes. Int J Mol Sci 2019; 20.
28.
Wang L, Li S, Luo H, et al. PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages. J Exp Clin Cancer Res 2022; 41: 303.
29.
Liu F, Liang Y, Sun R, et al. Astragalus mongholicus Bunge and Curcuma aromatica Salisb. inhibits liver metastasis of colon cancer by regulating EMT via the CXCL8/CXCR2 axis and PI3K/AKT/mTOR signaling pathway. Chin Med 2022; 17: 91.
30.
Dou R, Liu K, Yang C, et al. EMT-cancer cells-derived exosomal miR-27b-3p promotes circulating tumour cells-mediated metastasis by modulating vascular permeability in colorectal cancer. Clin Transl Med 2021; 11: e595.
31.
Wang T, Xu L, Jia R, et al. MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1. Acta Biochim Biophys Sin (Shanghai) 2017; 49: 383-391.
32.
Wang W, Hao Y, Zhang A, et al. miR-19a/b promote EMT and proliferation in glioma cells via SEPT7-AKT-NF-B pathway. Mol Ther Oncolytics 2021; 20: 290-305.
33.
Hu X, Binter M, Hufendiek K, et al. MiR-302d inhibits TGFB-induced EMT and promotes MET in primary human RPE cells. PLoS One 2022; 17: e0278158.
34.
Liu LH, Fang CK, Ge FC, et al. JPHYD Inhibits miR-21-5p/Smad7-Mediated Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells. J Oncol 2022; 2022: 7823433.
35.
Song J, Yang P, Li X, et al. Esophageal Cancer-Derived Extracellular Vesicle miR-21-5p Contributes to EMT of ESCC Cells by Disorganizing Macrophage Polarization. Cancers (Basel) 2021; 13.
36.
Xu Y. MiRNA-21-5p Accelerates EMT and Inhibits Apoptosis of Laryngeal Carcinoma via Inhibiting KLF6 Expression. Biochem Genet 2023; 61: 101-115.
37.
Mainsiouw L, Ryan ME, Hafizi S, et al. The molecular and clinical role of Tensin 1/2/3 in cancer. J Cell Mol Med 2023; 27: 1763-1774.
38.
Wang Z, Ye J, Dong F, et al. TNS1: Emerging Insights into Its Domain Function, Biological Roles, and Tumors. Biology (Basel) 2022; 11.
39.
Jiang Y, Chen F, Ren X, et al. RNA-binding protein COL14A1, TNS1, NUSAP1 and YWHAE are valid biomarkers to predict peritoneal metastasis in gastric cancer. 2022; 12: 830688.
40.
Tang C, Cai Y, Jiang H, et al. LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis. 2020; 12.